Detalles de la búsqueda
1.
Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis.
Mol Pharm
; 15(7): 2633-2645, 2018 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29799758
2.
Stable isotope-labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults.
Br J Clin Pharmacol
; 81(2): 235-45, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26382728
3.
Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes.
Clin Transl Sci
; 14(6): 2450-2460, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34378856
4.
In Vitro Evaluation of Poly(lactide-co-glycolide) In Situ Forming Gels for Bedaquiline Fumarate Salt and Pharmacokinetics Following Subcutaneous Injection in Rats.
Pharmaceutics
; 13(8)2021 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452192
5.
In vitro evaluation of poloxamer in situ forming gels for bedaquiline fumarate salt and pharmacokinetics following intramuscular injection in rats.
Int J Pharm X
; 1: 100016, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31517281
6.
Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
Clin Ther
; 29(2): 290-304, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17472821
7.
Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.
Clin Ther
; 29(7): 1476-86, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17825699
8.
Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval.
Ann Gen Psychiatry
; 6: 3, 2007 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-17261186
9.
Single-dose pharmacokinetics of ibrutinib in subjects with varying degrees of hepatic impairment.
Leuk Lymphoma
; 58(1): 185-194, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27267254
10.
A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.
Am J Psychiatry
; 163(3): 396-401, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16513859
11.
Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectable.
Eur Neuropsychopharmacol
; 16(4): 233-40, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16326078
12.
Pharmacokinetic profile and clinical efficacy of long-acting risperidone: potential benefits of combining an atypical antipsychotic and a new delivery system.
Drugs R D
; 6(3): 129-37, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15869316
13.
Helicobacter pylori treatment in children: defining a dose for rabeprazole as a part of a triple therapy regimen.
J Clin Pharmacol
; 55(5): 592-600, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25639255
14.
Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants.
Pharmacol Res Perspect
; 3(4): e00156, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26171235
15.
The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia.
Cancer Chemother Pharmacol
; 75(5): 907-16, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25724156
16.
Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia.
Schizophr Res
; 70(1): 91-100, 2004 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15246468
17.
In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis.
Clin Ther
; 26(8): 1261-73, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15476907
18.
Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers.
Clin Ther
; 25(6): 1687-99, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12860492
19.
Population pharmacokinetics of rabeprazole and dosing recommendations for the treatment of gastroesophageal reflux disease in children aged 1-11 years.
Clin Pharmacokinet
; 53(10): 943-57, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25168707
20.
Pharmacokinetics of rabeprazole granules versus tablets, and the effect of food on the pharmacokinetics of rabeprazole granules in healthy adults-cross-study comparison.
Clin Pharmacol Drug Dev
; 3(5): 406-16, 2014 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27129014